Metabolome-wide associations for all-cause, cardiovascular, and cancer mortality We first conducted a metabolome-wide association analysis in NHS/NHSII/HPFS. During a median follow-up of 22.6 years after blood collection, we documented 4288 deaths, including 867 cardiovascular and 1074 cancer deaths....
Notwithstanding the debilitating psychiatric implications of schizophrenia, individuals suffering from this disease experience reduced lifespans of 15–20 years on average brought on by a litany of aging-related diseases, such as cardiovascular disease, diabetes, and cancer [1,2,3,4]. A pivotal ...
In breast cancer patients the stage, the time elapsed since the diagnosis and the administration of chemotherapy are determinants of cellular and plasma hypercoagulability. The levels and the procoagulant activity of Pd-MP are interconnected with the biological activity and the overall burden of cancer...
血清与血浆的区别(The difference between serum and plasma).doc,血清与血浆的区别(The difference between serum and plasma) The difference between serum and plasma Plasma contains fibrinogen, not in serum. 1~2 hours after clotting, the blood clot retract
Introduction.Colorectal cancer (CRC) is the third most common cancer worldwide. Evaluation of patient response to the applied therapy regime is still challenging. Routine laboratory tests during follow-up do not provide necessary information on therapy efficacy. To improve life expectancy and quality ...
PSA Rapid Test (WB/Serum/Plasma) Intended Use Prostate cancer is one of the most common cancers in men. The incidence of prostate cancer increases with age, and new cases continue to increase with the increase in human life expectancy. Prostate-specific antigen is originally produced in the pr...
Cancer, 72 (1993), p. 108 View in ScopusGoogle Scholar 6 Berenson J, Wong R, Kim K, Brown N, Lichtenstein A Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma Blood, 70 (1987), p. 1550 View in ScopusGoogle Scholar 7 Billadeau D, Quam L...
The exclusion criteria were; systemic diseases such as diabetes, immunodeficiency, collagen-vascular and autoimmune disorders, cardiovascular disease, active cancer or its history, an infection or wound in the hip region, severe deformity of the hip joint, PLT and bleeding disorders, use of NSAIDs ...
Exclusion criteria were patients with on-going anticoagulant treatment, pregnancy, active cancer, short life expectancy or lack of capacity to leave approved consent. A case was defined if (a) VTE was confirmed by diagnostic imaging - compression venous ultrasonography (CUS) in patients with ...
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer Article20 July 2022 Introduction Bladder cancer is the tenth most common cancer and the sixth in men, where incidence and mortality are higher1. At diagnosis, 25% of patients present with aggressive muscle-invasive or metastat...